EMT2

Trial description
A randomised placebo-controlled phase III trial of the effect of the omega-3 fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases
Contact name
Dr Lizzie Smyth
Trial start date
Wednesday, October 30, 2019
Trial end date
Saturday, July 31, 2021
Trial tumour type
Colorectal
Show on Radiotherapy
No